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LETTER TO THE EDITOR 
 
Coagulation Monitoring 
 
Christoph K. Hofer, MD, DEAA, and Michael T. Ganter, MD, DEAA  
 
Institute of Anesthesiology and Intensive Care Medicine; Triemli City Hospital Zurich; 
Zurich, Switzerland; christoph.hofer@triemli.stzh.ch (Hofer) Institute of Anesthesiology; 
University Hospital Zurich; Zurich, Switzerland (Ganter)  
 
In Response: 
 
Casutt and Schüpfer (1) commented on the concept of the platelet function (PF) measured by 
the Sonoclot Analyzer (Sonoclot Coagulation & Platelet Function Analyzer, Sienco, Arvada, 
CO). Figure 3B in our article (2) presented an initial characterization of the Sonoclot 
Signature and attempted to illustrate that there is both a time component related to platelet 
activation as well as a clot retraction quality component. Although the graph only introduced 
the concept of PF, the text clearly states that PF as reported on the Sonoclot Analyzer is 
"derived from the timing and quality of the clot retraction." The actual algorithm for the 
numerical PF result was beyond the scope of the article. It is a numerical integration of the 
Sonoclot Signature that sums both the speed of platelet activation and quality of clot 
retraction. A description of the algorithm is available by contacting the manufacturer, Sienco. 
Historically, many publications have used the earlier Time-to-Peak result as a useful PF 
indicator. As Dr. Casutt correctly points out, Time-to-Peak is limited as a PF indicator 
because it fails to include the quality of clot retraction in its result. Furthermore, regarding Dr. 
Casutt’s comment about the obvious influence of heparin, no PF interpretation should be 
attempted on samples anticoagulated with heparin that rely on thrombin formation to activate 
platelets. Activated tests that include heparinase to neutralize the effects of heparin are 
available for the Sonoclot Analyzer (3).  
 
REFERENCES 
 
(1) Schüpfer G, Casutt M. Coagulation Monitoring. Anesth Analg 2007;2093 
(2) Ganter MT, Hofer CK. Coagulation monitoring: current techniques and clinical use of 
viscoelastic point-of-care coagulation devices. Anesth Analg 2008;106:1366–75 
(3) Tucci MA, Ganter MT, Hamiel CR, Klaghofer R, Zollinger A, Hofer CK. Platelet function 
monitoring with the Sonoclot analyzer after in vitro tirofiban and heparin administration. J 
Thorac Cardiovasc Surg 2006;131:1314–22 
